BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 12160248)

  • 21. C-deletion mutation of the p53 gene at exon 4 of codon 63 in the saliva of oral squamous cell carcinoma in central India: a preliminary study.
    Mewara A; Gadbail AR; Patil S; Chaudhary M; Chavhan SD
    J Investig Clin Dent; 2010 Nov; 1(2):108-13. PubMed ID: 25427266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RT-PCR amplification of RNA extracted from formalin-fixed, paraffin-embedded oral cancer sections: analysis of p53 pathway.
    Tachibana M; Shinagawa Y; Kawamata H; Omotehara F; Horiuchi H; Ohkura Y; Kubota K; Imai Y; Fujibayashi T; Fujimori T
    Anticancer Res; 2003; 23(3C):2891-6. PubMed ID: 12926130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low incidence of p53 mutations in betel quid and tobacco chewing-associated oral squamous carcinoma from India.
    Kannan K; Munirajan AK; Krishnamurthy J; Bhuvarahamurthy V; Mohanprasad BK; Panishankar KH; Tsuchida N; Shanmugam G
    Int J Oncol; 1999 Dec; 15(6):1133-6. PubMed ID: 10568819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic role of p21WAF1 expression in areca quid chewing and smoking-associated oral squamous cell carcinoma in Taiwan.
    Yen-Ping Kuo M; Huang JS; Kok SH; Kuo YS; Chiang CP
    J Oral Pathol Med; 2002 Jan; 31(1):16-22. PubMed ID: 11896818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 mutation, murine double minute 2 amplification, and human papillomavirus infection are frequently involved but not associated with each other in esophageal squamous cell carcinoma.
    Shibagaki I; Tanaka H; Shimada Y; Wagata T; Ikenaga M; Imamura M; Ishizaki K
    Clin Cancer Res; 1995 Jul; 1(7):769-73. PubMed ID: 9816044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus infection in Egyptian esophageal carcinoma: correlation with p53, p21, mdm2, C-erbB2 and impact on survival.
    Bahnassy AA; Zekri AR; Abdallah S; El-Shehaby AM; Sherif GM
    Pathol Int; 2005 Feb; 55(2):53-62. PubMed ID: 15693850
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53 gene mutations and expression of p53 and mdm2 proteins in invasive breast carcinoma. A comparative analysis with clinico-pathological factors.
    Günther T; Schneider-Stock R; Rys J; Niezabitowski A; Roessner A
    J Cancer Res Clin Oncol; 1997; 123(7):388-94. PubMed ID: 9260591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p53 alterations in betel quid- and tobacco-associated oral squamous cell carcinomas from Taiwan.
    Wong YK; Liu TY; Chang KW; Lin SC; Chao TW; Li PL; Chang CS
    J Oral Pathol Med; 1998 Jul; 27(6):243-8. PubMed ID: 9707275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relative quantitation of p53 and MDM2 gene expression in leiomyosarcoma; real-time semi-quantitative reverse transcription-polymerase chain reaction.
    Miyajima K; Tamiya S; Oda Y; Adachi T; Konomoto T; Toyoshiba H; Masuda K; Tsuneyoshi M
    Cancer Lett; 2001 Mar; 164(2):177-88. PubMed ID: 11179833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas.
    Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M
    J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
    Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
    Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from India.
    Saranath D; Tandle AT; Teni TR; Dedhia PM; Borges AM; Parikh D; Sanghavi V; Mehta AR
    Oral Oncol; 1999 May; 35(3):242-50. PubMed ID: 10621843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Correlation between p53 gene mutations and circulating antibodies in betel- and tobacco-consuming North Indian population.
    Ralhan R; Agarwal S; Nath N; Mathur M; Wasylyk B; Srivastava A
    Oral Oncol; 2001 Apr; 37(3):243-50. PubMed ID: 11287278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heterogeneous distribution of P53 immunoreactivity in human lung adenocarcinoma correlates with MDM2 protein expression, rather than with P53 gene mutation.
    Koga T; Hashimoto S; Sugio K; Yoshino I; Nakagawa K; Yonemitsu Y; Sugimachi K; Sueishi K
    Int J Cancer; 2001 Jul; 95(4):232-9. PubMed ID: 11400116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some oral carcinomas from Sri Lankan betel/tobacco chewers overexpress p53 oncoprotein but lack mutations in exons 5-9.
    Ranasinghe A; MacGeoch C; Dyer S; Spurr N; Johnson NW
    Anticancer Res; 1993; 13(6A):2065-8. PubMed ID: 8297114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P53 (Pro72Arg) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, niswar and manpuri addicted patients of Pakistan.
    Saleem S; Azhar A; Hameed A; Khan MA; Abbasi ZA; Qureshi NR; Ajmal M
    Oral Oncol; 2013 Aug; 49(8):818-23. PubMed ID: 23683469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutations of the adenomatous polyposis coli gene in areca quid and tobacco-associated oral squamous cell carcinomas in Taiwan.
    Kok SH; Lee JJ; Hsu HC; Chiang CP; Kuo YS; Kuo MY
    J Oral Pathol Med; 2002 Aug; 31(7):395-401. PubMed ID: 12165057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SSCP.
    Trivedy C; Warnakulasuriya KA; Tavassoli M; Steingrimsdottir H; Penhallow J; Maher R; Johnson NW
    J Oral Pathol Med; 1998 Feb; 27(2):72-7. PubMed ID: 9526733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of microsatellite instability, inactivation of mismatch repair genes, p53 mutation, and human papillomavirus infection in Korean oral cancer patients.
    Shin KH; Park KH; Hong HJ; Kim JM; Oh JE; Choung PH; Min BM
    Int J Oncol; 2002 Aug; 21(2):297-302. PubMed ID: 12118324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer.
    Wang YC; Lin RK; Tan YH; Chen JT; Chen CY; Wang YC
    J Clin Oncol; 2005 Jan; 23(1):154-64. PubMed ID: 15625370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.